share_log

Morgan Stanley Downgrades Evotec to Underweight, Announces $16 Price Target

Benzinga Real-time News ·  Aug 10, 2022 08:08

Morgan Stanley analyst James Quigley downgrades Evotec (NASDAQ:EVO) from Overweight to Underweight and announces $16 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment